These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9871746)

  • 1. 3-trifluoromethylcarbacephems: synthesis of broad spectrum antibacterial compounds.
    Cook GK; Hornback WJ; McDonald JH; Munroe JE; Snyder NJ
    Bioorg Med Chem Lett; 1998 May; 8(10):1261-6. PubMed ID: 9871746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100.
    Hiraoka M; Masuyoshi S; Tomatsu K; Inoue M; Mitsuhashi S
    Eur J Clin Microbiol; 1987 Oct; 6(5):559-63. PubMed ID: 3501756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial activity of novel 3-substituted carbacephems.
    Mochida K; Ogasa T; Shimada J; Hirata T; Sato K; Okachi R
    J Antibiot (Tokyo); 1989 Feb; 42(2):283-92. PubMed ID: 2925519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.
    Galán JC; Morosini MI; Baquero MR; Reig M; Baquero F
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2551-7. PubMed ID: 12878518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of cefaclor (author's transl)].
    Knothe H
    Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminothiazolylglycyl derivatives of carbacephems. I. Synthesis and antibacterial activity of novel carbacephems with substituted aminothiazolyl groups.
    Mochida K; Shiraki C; Yamasaki M; Hirata T; Sato K; Okachi R
    J Antibiot (Tokyo); 1987 Jan; 40(1):14-21. PubMed ID: 3558115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ceftobiprole activity against a variety of gram-negative pathogens, including Escherichia coli, Haemophilus influenzae (β-lactamase positive and β-lactamase negative), and Klebsiella pneumoniae, in a rabbit meningitis model.
    Stucki A; Cottagnoud M; Acosta F; Egerman U; Läuffer J; Cottagnoud P
    Antimicrob Agents Chemother; 2012 Feb; 56(2):921-5. PubMed ID: 22064544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of a new cephalosporin, cefotaxime.
    Russell AD; Rogers DT
    J Appl Bacteriol; 1980 Aug; 49(1):137-41. PubMed ID: 6253429
    [No Abstract]   [Full Text] [Related]  

  • 10. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strains.
    Li Q; Lee JY; Castillo R; Hixon MS; Pujol C; Doppalapudi VR; Shepard HM; Wahl GM; Lobl TJ; Chan MF
    Antimicrob Agents Chemother; 2002 May; 46(5):1262-8. PubMed ID: 11959554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry of cephalosporin antibiotics. XXIV. 3-Halo- and 3-methoxy-3-cephems.
    Chauvette RR; Pennington PA
    J Am Chem Soc; 1974 Jul; 96(15):4986-7. PubMed ID: 4604213
    [No Abstract]   [Full Text] [Related]  

  • 13. Ceftibuten and bactericidal kinetics. Comparative in vitro activity against Enterobacteriaceae producing extended spectrum beta-lactamases.
    Bauernfeind A
    Diagn Microbiol Infect Dis; 1991; 14(1):89-92. PubMed ID: 2013215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in-vitro activity of a new oral carbacephem, LY163892.
    Howard AJ; Dunkin KT
    J Antimicrob Chemother; 1988 Oct; 22(4):445-56. PubMed ID: 3060458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of a series of parenteral 3'-quaternary ammonium cephalosporins.
    Brown RF; Kinnick MD; Morin JM; Vasileff RT; Counter FT; Davidson EO; Ensminger PW; Eudaly JA; Kasher JS; Katner AS
    J Med Chem; 1990 Aug; 33(8):2114-21. PubMed ID: 2115587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationship of new cephalosporins with amino heterocycles at C-7. Dependence of the antibacterial spectrum and beta-lactamase stability on the pKa of the C-7 heterocycle.
    Jung F; Delvare C; Boucherot D; Hamon A; Ackerley N; Betts MJ
    J Med Chem; 1991 Mar; 34(3):1110-6. PubMed ID: 2002452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-lactamase stability and antibacterial activity of cefpirome alone and in combination with other antibiotics.
    Bakhtiar M; Selwyn S
    Drugs Exp Clin Res; 1989; 15(10):477-82. PubMed ID: 2698794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin.
    Ripa S; Prenna M
    Chemotherapy; 1979; 25(1):9-13. PubMed ID: 33784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of cefamandole in vitro.
    Meyers BR; Hirschman SZ
    J Infect Dis; 1978 May; 137 Suppl():S25-S31. PubMed ID: 349095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of cefcanel.
    Bergan T; da Fonseca J
    Chemotherapy; 1993; 39(2):96-104. PubMed ID: 8458252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.